Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15084995 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL28763664 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL12805060 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL262589 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL890477 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL262140 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL15215 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL21834095 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL20543294 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL2784183 | 1.00 | TSHR (0.95) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159581-A | Epoxy resin composition, cured product thereof, and laminate | DIC株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-20240059827-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE | DIC CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| CN-116948179-A | Modified cage-type oligomeric silsesquioxane, organic silicon sealant and preparation method thereof, flexible semiconductor device and film packaging method | 深圳市首骋新材料科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116925121-A | Organopolysiloxane, organopolysiloxane composition, method for producing the same, flexible semiconductor device, and film encapsulation method for the same | 深圳市首骋新材料科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116925122-A | Organosiloxane monomer, organosiloxane sealant, preparation method thereof, thin film packaging method and flexible semiconductor device | 深圳市首骋新材料科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-4261037-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE | DIC Corporation (JP) | 2023-10-18 | — | — | EP | disclosed |
| EP-3730531-B1 | EPOXY COMPOUND, COMPOSITION, CURED PRODUCT AND LAMINATE | DAINIPPON INK & CHEMICALS (JP) | 2023-10-04 | — | — | EP | disclosed |
| CN-116829353-A | Epoxy resin composition, cured product thereof, and laminate | DIC株式会社 | 2023-09-29 | — | — | CN | disclosed |
| US-11760711-B2 | Epoxy compound, composition, cured product and laminate | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11685807-B2 | Resin composition, cured product, laminate, and electronic member | DIC CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| CN-112236477-B | Resin composition, cured product, laminate, and electronic component | DIC株式会社 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023095615-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE | DIC株式会社 | 2023-06-01 | — | — | WO | disclosed |
| CN-111566141-B | Epoxy compound, composition, cured product, and laminate | DIC株式会社 | 2023-05-02 | — | — | CN | disclosed |
| EP-3854848-B1 | RESIN COMPOSITION, CURED OBJECT, AND LAMINATE | DAINIPPON INK & CHEMICALS (JP) | 2023-01-25 | — | — | EP | disclosed |
| CN-111527063-B | Hydroxyl compound, composition, cured product, and laminate | DIC株式会社 | 2022-11-08 | — | — | CN | disclosed |
| EP-3854848-A1 | RESIN COMPOSITION, CURED OBJECT, AND LAMINATE | DIC Corporation (JP) | 2021-07-28 | — | — | EP | disclosed |
| CN-112236477-A | Resin composition, cured product, and laminate | DIC株式会社 | 2021-01-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760711-B2 | Epoxy compound, composition, cured product and laminate | ARL1, DOT1L, RFT1 | TSHR 4665/4885ALDH1A1 1078/4885TDP1 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.